BioRestorative Therapies, Inc. (BRTX) Insider Trading Disclosures
BioRestorative Therapies, Inc. (BRTX) is a publicly traded company on the Nasdaq, categorized under SIC 8090 (Services-Misc Health & Allied Services, NEC). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BRTX
CIK: 1505497
Exchange: Nasdaq
SIC 8090: Services-Misc Health & Allied Services, NEC
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerWillem van der Berg
Audit LocationMarlton, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-09 | 2026-10-07 | CURRENT REPORT | 0001213900-26-108467 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-04 | CURRENT REPORT | 0001213900-26-099018 | View SEC Doc Filr Page |
| 8-K/A | 2026-09-10 | 2026-08-26 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-098820 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-02 | CURRENT REPORT | 0001213900-26-096810 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-08-26 | CURRENT REPORT | 0001213900-26-096337 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-21 | CURRENT REPORT | 0001213900-26-093566 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001493152-26-038425 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-07 | 8-K | 0001493152-26-038391 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-03 | — | SCHEDULE 13G/A Filing | 0001094891-26-000263 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-13 | 3 Filing | 0001213900-26-083461 | View SEC Doc Filr Page |
| 3 | 2026-07-24 | 2026-07-14 | PRIMARY DOCUMENT | 0002146283-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-08 | 8-K | 0001493152-26-033593 | View SEC Doc Filr Page |
| 3 | 2026-06-18 | 2026-06-10 | 3 Filing | 0001213900-26-070160 | View SEC Doc Filr Page |
| 3 | 2026-06-18 | 2026-06-10 | 3 Filing | 0001213900-26-069973 | View SEC Doc Filr Page |
| 3 | 2026-06-17 | 2026-06-10 | 3 Filing | 0001213900-26-069704 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-10 | CURRENT REPORT FILING | 0001021771-26-000093 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-10 | CURRENT REPORT FILING | 0001021771-26-000091 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-26 | FORM 8-K DATED MARCH 26, 2026 | 0001021771-26-000084 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001700205-26-000004 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001493152-26-023126 | View SEC Doc Filr Page |
| 8-K | 2026-05-01 | 2026-05-01 | CURRENT REPORT FILING | 0001021771-26-000068 | View SEC Doc Filr Page |
| 424B3 | 2026-04-30 | — | 424B3 | 0001493152-26-020495 | View SEC Doc Filr Page |
| EFFECT | 2026-04-28 | — | EFFECT Filing | 9999999995-26-001353 | View SEC Doc Filr Page |
| POS AM | 2026-04-27 | — | POS AM | 0001493152-26-019129 | View SEC Doc Filr Page |
| 8-K | 2026-04-23 | 2026-04-23 | CURRENT REPORT FILING | 0001021771-26-000058 | View SEC Doc Filr Page |